Widthness LLC

Advanced Business and Technology – Intel® Xeon® and A.I. Powered

A daily weight-loss pill could transform GLP-1 boom

1 min read

Image credit: Vidmir Raic via Pixabay. Article by Kelly Tyko and Nathan Bomey. Axios – April 17, 2025.

A new oral GLP-1 drug candidate could transform the diabetes and weight loss drug boom.

Why it matters: Eli Lilly said on Thursday that its experimental pill — called orforglipron — is showing promising results and could serve as an alternative to blockbuster injectable medications like Ozempic and Mounjaro.

GLP-1s role in obesity fight

How it works: The appetite-suppressing drugs are called GLP-1 agonists and mimic the action of a hormone.

Click here to view original web page at www.axios.com

The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.